$75.11-1.25 (-1.64%)
Ingersoll Rand Inc.
Ingersoll Rand Inc. in the Industrials sector is trading at $75.11 with a market capitalization of $29.6B. Wall Street consensus targets $96.25 (13 analysts), implying a +28.1% move over the next 12 months. The stock is currently 26% below its 52-week high of $100.96, remaining 8.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.05B↑ | $1.85B↓ | $2.09B↑ | $1.96B↑ | $1.89B |
| Gross Profit | $862.60M↑ | $792.40M↓ | $890.70M↑ | $855.20M↑ | $824.90M |
| Operating Income | $358.50M↑ | $314.20M↓ | $423.90M↑ | $398.50M↑ | $363.20M |
| Net Income | $256.80M↑ | $192.10M↓ | $266.10M↑ | $244.10M↑ | -$115.30M |
Ingersoll Rand Inc. provides mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industri...

Over the last six months, Ingersoll Rand’s shares have sunk to $78.59, producing a disappointing 16.4% loss - a stark contrast to the S&P 500’s 12.3% gain. This may have investors wondering how to approach the situation.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
DCI heads into fiscal Q4 with higher sales and earnings estimates, supported by segment growth and the Facet Filtration acquisition.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems to be baking in a prolonged downturn as the industry has shed 1.5% over the past six months. This drawdown is a noticeable divergence from the S&P 500’s 10.9% return.

NDSN heads into fiscal Q3 with expected sales and earnings growth, supported by demand across key segments, while rising costs may pressure margins.
Academic risk and quality models computed from IR's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 31.1% reading.
Fama-French 5-factor market beta. The five factors explain 47% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.